Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
19135 | 454 | 46.4 | 93% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
880 | 10788 | HEREDITARY HEMORRHAGIC TELANGIECTASIA//ENDOGLIN//TGF BETA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | LTBP | Author keyword | 44 | 78% | 6% | 29 |
2 | ALPHA V BETA 6 | Author keyword | 21 | 75% | 3% | 15 |
3 | INTEGRIN ALPHAVBETA6 | Author keyword | 14 | 100% | 2% | 7 |
4 | BETA 6 INTEGRIN | Author keyword | 11 | 78% | 2% | 7 |
5 | INTEGRIN ALPHA V BETA 6 | Author keyword | 9 | 55% | 3% | 12 |
6 | ALPHAVBETA6 | Author keyword | 9 | 83% | 1% | 5 |
7 | NEWCASTLE BOWEL CANC ABORAT | Address | 8 | 100% | 1% | 5 |
8 | ALPHA V BETA 6 INTEGRIN | Author keyword | 6 | 58% | 2% | 7 |
9 | LATENT TGF BETA BINDING PROTEIN | Author keyword | 4 | 47% | 2% | 7 |
10 | ALPHA V BETA 8 INTEGRIN | Author keyword | 3 | 100% | 1% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LTBP | 44 | 78% | 6% | 29 | Search LTBP | Search LTBP |
2 | ALPHA V BETA 6 | 21 | 75% | 3% | 15 | Search ALPHA+V+BETA+6 | Search ALPHA+V+BETA+6 |
3 | INTEGRIN ALPHAVBETA6 | 14 | 100% | 2% | 7 | Search INTEGRIN+ALPHAVBETA6 | Search INTEGRIN+ALPHAVBETA6 |
4 | BETA 6 INTEGRIN | 11 | 78% | 2% | 7 | Search BETA+6+INTEGRIN | Search BETA+6+INTEGRIN |
5 | INTEGRIN ALPHA V BETA 6 | 9 | 55% | 3% | 12 | Search INTEGRIN+ALPHA+V+BETA+6 | Search INTEGRIN+ALPHA+V+BETA+6 |
6 | ALPHAVBETA6 | 9 | 83% | 1% | 5 | Search ALPHAVBETA6 | Search ALPHAVBETA6 |
7 | ALPHA V BETA 6 INTEGRIN | 6 | 58% | 2% | 7 | Search ALPHA+V+BETA+6+INTEGRIN | Search ALPHA+V+BETA+6+INTEGRIN |
8 | LATENT TGF BETA BINDING PROTEIN | 4 | 47% | 2% | 7 | Search LATENT+TGF+BETA+BINDING+PROTEIN | Search LATENT+TGF+BETA+BINDING+PROTEIN |
9 | ALPHA V BETA 8 INTEGRIN | 3 | 100% | 1% | 3 | Search ALPHA+V+BETA+8+INTEGRIN | Search ALPHA+V+BETA+8+INTEGRIN |
10 | LATENT TGF BETA | 3 | 42% | 1% | 5 | Search LATENT+TGF+BETA | Search LATENT+TGF+BETA |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | 8 CYSTEINE REPEAT | 32 | 80% | 4% | 20 |
2 | ALPHA V BETA 6 INTEGRIN | 26 | 54% | 7% | 34 |
3 | GELATINASE B SECRETION | 24 | 82% | 3% | 14 |
4 | ALPHA V BETA 6 | 24 | 56% | 6% | 29 |
5 | FIBROBLAST EXTRACELLULAR MATRIX | 19 | 80% | 3% | 12 |
6 | INTEGRIN ALPHAVBETA6 | 14 | 65% | 3% | 13 |
7 | TGF BETA 1 ACTIVATION | 13 | 80% | 2% | 8 |
8 | BETA 6 INTEGRIN | 10 | 63% | 2% | 10 |
9 | MOLECULAR WEIGHT COMPLEX | 9 | 19% | 9% | 43 |
10 | LTBP 4 | 8 | 75% | 1% | 6 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Integrin-TGF-beta crosstalk in fibrosis, cancer and wound healing | 2010 | 162 | 77 | 40% |
Latent transforming growth factor-beta (TGF-beta) binding proteins: Orchestrators of TGF-beta availability | 2005 | 190 | 49 | 69% |
Defining the Role of Integrin alpha v beta 6 in Cancer | 2009 | 43 | 51 | 71% |
Integrin-mediated regulation of TGF beta in fibrosis | 2013 | 14 | 53 | 40% |
Integrins and the activation of latent transforming growth factor beta 1 - An intimate relationship | 2008 | 161 | 105 | 34% |
Matrix control of transforming growth factor-beta function | 2012 | 35 | 79 | 38% |
TGF beta: a sleeping giant awoken by integrins | 2011 | 46 | 70 | 49% |
Integrin-mediated activation of latent transforming growth factor beta | 2005 | 92 | 43 | 49% |
Latency, activation, and binding proteins of TGF-beta | 2001 | 162 | 98 | 33% |
Integrin-Mediated Transforming Growth Factor-beta Activation, a Potential Therapeutic Target in Fibrogenic Disorders | 2009 | 39 | 101 | 36% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NEWCASTLE BOWEL CANC ABORAT | 8 | 100% | 1.1% | 5 |
2 | CANARY CANC EARLY DETECT | 2 | 67% | 0.4% | 2 |
3 | DISCIPLINE SURG SCI | 1 | 21% | 1.3% | 6 |
4 | MOL GENOM IMAGING | 1 | 17% | 1.5% | 7 |
5 | BIOMEDICUM A506 | 1 | 50% | 0.2% | 1 |
6 | CANC BARTS LONDON | 1 | 50% | 0.2% | 1 |
7 | CARDIOTHORAC BORDEAUX | 1 | 50% | 0.2% | 1 |
8 | HAARTMAN PROGRAMS UNIT | 1 | 50% | 0.2% | 1 |
9 | MED RAYMOND BEVERLY SACKLER FDN | 1 | 50% | 0.2% | 1 |
10 | MILTENYI BIOTEC GMBH | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000158122 | TGF BETA RECEPTORS//TGF BETA RECEPTOR//MED MED CELL BIOL |
2 | 0.0000138774 | MARFAN SYNDROME//FIBRILLIN//FBN1 |
3 | 0.0000118653 | CTHRC1//COLLAGEN TRIPLE HELIX REPEAT CONTAINING 1//CAROTID ARTERY RESTENOSIS |
4 | 0.0000114700 | ALPHA 6 BETA 4 INTEGRIN//INTEGRIN ALPHA 6 BETA 4//CANC BIOL ANGIOGENESIS |
5 | 0.0000114146 | ALPHAVBETA3 INTEGRIN//CILENGITIDE//ALPHAVBETA3 |
6 | 0.0000101174 | PHENOTYPE INDUCTION//PHOSPHORYLATED SMAD2//SMAD UBIQUITINATION REGULATORY FACTOR 2 |
7 | 0.0000090802 | NEPHRONECTIN//VLA 1//ALPHA 8 INTEGRIN |
8 | 0.0000085643 | ALK5 INHIBITOR//CELL BASED LUCIFERASE REPORTER ASSAY//TGFB1 |
9 | 0.0000074192 | FIBULIN 1//EFEMP1//FIBULIN 3 |
10 | 0.0000058244 | TELENCEPHALIN//ICAM 5//NEURONAL RECOGNIT MOL |